A detailed history of Geode Capital Management, LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 628,054 shares of MEDP stock, worth $215 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
628,054
Previous 583,683 7.6%
Holding current value
$215 Million
Previous $240 Million 12.87%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$320.58 - $457.29 $14.2 Million - $20.3 Million
44,371 Added 7.6%
628,054 $209 Million
Q2 2024

Aug 09, 2024

BUY
$372.0 - $424.34 $18.9 Million - $21.6 Million
50,934 Added 9.56%
583,683 $240 Million
Q1 2024

May 13, 2024

BUY
$284.87 - $413.31 $11.3 Million - $16.5 Million
39,818 Added 8.08%
532,749 $215 Million
Q4 2023

Feb 13, 2024

BUY
$227.52 - $312.68 $1.66 Million - $2.28 Million
7,297 Added 1.5%
492,931 $151 Million
Q3 2023

Nov 13, 2023

BUY
$233.98 - $281.67 $1.85 Million - $2.22 Million
7,888 Added 1.65%
485,634 $118 Million
Q2 2023

Aug 11, 2023

SELL
$187.26 - $240.17 $20.6 Million - $26.5 Million
-110,198 Reduced 18.74%
477,746 $115 Million
Q1 2023

May 15, 2023

BUY
$174.31 - $239.52 $371,105 - $509,938
2,129 Added 0.36%
587,944 $111 Million
Q4 2022

Feb 13, 2023

BUY
$153.06 - $226.57 $7.88 Million - $11.7 Million
51,462 Added 9.63%
585,815 $124 Million
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $4.26 Million - $5.36 Million
-29,348 Reduced 5.21%
534,353 $84 Million
Q2 2022

Aug 12, 2022

BUY
$130.2 - $168.03 $2.52 Million - $3.25 Million
19,343 Added 3.55%
563,701 $84.4 Million
Q1 2022

May 13, 2022

BUY
$138.87 - $214.31 $1.06 Million - $1.63 Million
7,605 Added 1.42%
544,358 $89.1 Million
Q4 2021

Feb 11, 2022

BUY
$182.74 - $227.9 $1.77 Million - $2.21 Million
9,686 Added 1.84%
536,753 $117 Million
Q3 2021

Nov 12, 2021

BUY
$170.18 - $198.21 $994,702 - $1.16 Million
5,845 Added 1.12%
527,067 $99.8 Million
Q2 2021

Aug 13, 2021

BUY
$158.62 - $194.3 $3.93 Million - $4.81 Million
24,763 Added 4.99%
521,222 $92.1 Million
Q1 2021

May 12, 2021

BUY
$132.02 - $168.26 $4.89 Million - $6.23 Million
37,040 Added 8.06%
496,459 $81.4 Million
Q4 2020

Feb 12, 2021

BUY
$109.38 - $149.19 $1.86 Million - $2.53 Million
16,982 Added 3.84%
459,419 $64 Million
Q3 2020

Nov 13, 2020

SELL
$92.95 - $130.61 $209,509 - $294,394
-2,254 Reduced 0.51%
442,437 $49.4 Million
Q2 2020

Aug 13, 2020

SELL
$68.08 - $95.68 $424,274 - $596,277
-6,232 Reduced 1.38%
444,691 $41.4 Million
Q1 2020

May 14, 2020

BUY
$61.71 - $101.95 $1.46 Million - $2.42 Million
23,691 Added 5.55%
450,923 $33.1 Million
Q4 2019

Feb 13, 2020

BUY
$70.08 - $84.64 $301,764 - $364,459
4,306 Added 1.02%
427,232 $35.9 Million
Q3 2019

Nov 12, 2019

BUY
$62.38 - $85.89 $1.32 Million - $1.82 Million
21,192 Added 5.28%
422,926 $35.5 Million
Q2 2019

Aug 14, 2019

BUY
$53.64 - $65.42 $2.63 Million - $3.21 Million
49,117 Added 13.93%
401,734 $26.3 Million
Q1 2019

May 14, 2019

BUY
$49.38 - $70.58 $1.56 Million - $2.24 Million
31,679 Added 9.87%
352,617 $20.8 Million
Q4 2018

Feb 13, 2019

BUY
$46.97 - $63.98 $775,991 - $1.06 Million
16,521 Added 5.43%
320,938 $17 Million
Q3 2018

Nov 13, 2018

BUY
$43.25 - $63.74 $4.97 Million - $7.33 Million
114,945 Added 60.67%
304,417 $18.2 Million
Q2 2018

Aug 14, 2018

BUY
$34.03 - $45.46 $1.74 Million - $2.33 Million
51,173 Added 37.0%
189,472 $8.15 Million
Q1 2018

May 15, 2018

BUY
$32.03 - $39.05 $675,416 - $823,447
21,087 Added 17.99%
138,299 $4.83 Million
Q4 2017

Feb 13, 2018

BUY
$32.46 - $38.31 $505,402 - $596,486
15,570 Added 15.32%
117,212 $4.25 Million
Q3 2017

Nov 14, 2017

BUY
$27.43 - $33.11 $224,788 - $271,336
8,195 Added 8.77%
101,642 $3.24 Million
Q2 2017

Aug 14, 2017

BUY
N/A
93,447
93,447 $2.71 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.7B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.